We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TU icon
9176
CALL
Telus
TU
$15.3B
$377K ﹤0.01%
16,900
+7,700
+84% +$190K
ONEM
9177
PUT
DELISTED
1Life Healthcare
ONEM
$377K ﹤0.01%
48,100
-34,900
-42% -$300K
BBP icon
9178
Virtus Biotech ETF
BBP
$107M
$376K ﹤0.01%
9,127
+316
+4% +$12.6K
CATY icon
9179
PUT
Cathay General Bancorp
CATY
$4.31B
$376K ﹤0.01%
+9,600
New +$392K
DAWN
9180
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
$376K ﹤0.01%
+21,000
New +$217K
DEI icon
9181
PUT
Douglas Emmett
DEI
$1.94B
$376K ﹤0.01%
16,800
+5,500
+49% +$153K
EDV icon
9182
Vanguard World Funds Extended Duration ETF
EDV
$3.42B
$376K ﹤0.01%
3,759
-111,001
-97% -$11.5M
OCFT
9183
DELISTED
OneConnect Financial Technology
OCFT
$376K ﹤0.01%
22,015
+18,138
+468% +$257K
RDNW
9184
RideNow Group
RDNW
$250M
$376K ﹤0.01%
+25,556
New +$500K
RDUS
9185
PUT
DELISTED
Radius Health, Inc.
RDUS
$376K ﹤0.01%
36,300
+1,800
+5% +$13.4K
COHU icon
9186
CALL
Cohu
COHU
$2.99B
$375K ﹤0.01%
13,500
-10,900
-45% -$301K
FCFS icon
9187
CALL
FirstCash
FCFS
$9.37B
$375K ﹤0.01%
5,400
-800
-13% -$57.6K
IRT icon
9188
PUT
Independence Realty Trust
IRT
$3.94B
$375K ﹤0.01%
+18,100
New +$436K
LGND icon
9189
PUT
Ligand Pharmaceuticals
LGND
$5.92B
$375K ﹤0.01%
6,733
-3,526
-34% -$200K
MFIN icon
9190
Medallion Financial
MFIN
$257M
$375K ﹤0.01%
58,497
+35,929
+159% +$274K
JPS
9191
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$375K ﹤0.01%
51,632
-9,743
-16% -$74.4K
SUMO
9192
PUT
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$375K ﹤0.01%
50,100
+2,900
+6% +$25.4K
CWB icon
9193
CALL
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.8B
$374K ﹤0.01%
5,800
-4,500
-44% -$312K
DJAN icon
9194
FT Vest US Equity Deep Buffer ETF January
DJAN
$483M
$374K ﹤0.01%
+12,411
New +$388K
DYAI icon
9195
CALL
Dyadic International
DYAI
$32M
$374K ﹤0.01%
122,600
-4,900
-4% -$12.1K
NTGR icon
9196
CALL
NETGEAR
NTGR
$616M
$374K ﹤0.01%
20,200
+5,000
+33% +$102K
RXT icon
9197
PUT
Rackspace Technology
RXT
$1.02B
$374K ﹤0.01%
52,100
-36,900
-41% -$333K
EE icon
9198
PUT
Excelerate Energy
EE
$1.13B
$373K ﹤0.01%
+18,700
New +$475K
NEOG icon
9199
PUT
Neogen
NEOG
$2.56B
$373K ﹤0.01%
15,500
-600
-4% -$16.1K
PBI icon
9200
CALL
Pitney Bowes
PBI
$2.23B
$373K ﹤0.01%
103,100
+55,300
+116% +$252K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.